Recruiting Migraine Studies in Washington D.c.
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine....
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine....
About Migraine Clinical Trials in Washington D.c.
Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.
There are currently 2 migraine clinical trials recruiting participants in Washington D.c., DC. These studies are seeking a combined 925 participants. Research is being sponsored by Pfizer, H. Lundbeck A/S. Clinical trial participation is free and participants receive study-related medical care at no cost.
Migraine Clinical Trials in Washington D.c. — FAQ
Are there migraine clinical trials in Washington D.c.?
Yes, there are 2 migraine clinical trials currently recruiting in Washington D.c., DC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Washington D.c.?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Washington D.c. research site will contact you about next steps.
Are clinical trials in Washington D.c. free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Washington D.c. studies also compensate for your time and travel.
What migraine treatments are being tested?
The 2 active trials in Washington D.c. are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.
Data updated March 2, 2026 from ClinicalTrials.gov